Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Misonix, a developer of minimally invasive ultrasonic medical device technology, has entered into a definitive, five-year distribution agreement with DTL Medical based in Craiova, Romania.
Subscribe to our email newsletter
Under the terms of the agreement, DTL will market the Sonablate 500 high intensity focused ultrasound (HIFU) system as a mobile, ‘fee for use’ service to hospitals in Romania and Bulgaria.
Misonix and DTL will share the ‘fee for use’ revenue for the length of the agreement plus any extension periods. Procedure minimums for ‘fee per use’ revenue are part of the agreement.
The Sonablate is a HIFU instrument used for the trans-rectal ablation of tumors of the prostate gland. Characteristics of HIFU, when used for this purpose, are clinical outcomes similar to other treatment modalities, but with low instances of urinary incontinence and sexual impotence, said Misonix.
Michael McManus, Jr, president and CEO of Misonix, said: “Misonix is pleased to partner with DTL Medical to provide prostate HIFU to hospitals in Romania and Bulgaria. DTL’s strategy of introducing advanced medical equipment to underserved markets is well known to us. DTL’s commitment to the mobile ‘fee for service’ business segment makes them a particularly appealing distribution partner, whose strengths blend well with Misonix’s business strategy for HIFU.”